Ligand validation:6KJ0

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KJ0_NAG_B_917	93%	49%	0.057	0.949	0.49	1.47	-	1	0	0	100%	0.9333
6KJ0_NAG_A_917	87%	55%	0.072	0.942	0.61	1.13	-	1	0	0	100%	0.9333
6KJ0_NAG_A_912	72%	50%	0.09	0.913	0.62	1.31	-	2	0	0	100%	0.9333
6KJ0_NAG_B_912	67%	51%	0.087	0.895	0.72	1.17	-	1	0	0	100%	0.9333
6KJ0_NAG_B_911	42%	42%	0.121	0.839	0.4	1.79	-	2	0	0	100%	0.9333
6KJ0_NAG_A_911	27%	43%	0.136	0.781	0.65	1.54	-	2	0	0	100%	0.9333
6KJ0_NAG_A_918	13%	48%	0.157	0.692	0.49	1.5	-	2	0	0	100%	0.9333
6KJ0_NAG_B_918	10%	42%	0.174	0.674	0.91	1.31	1	2	0	0	100%	0.9333
7YO7_NAG_A_902	92%	32%	0.07	0.96	0.78	1.87	-	4	0	0	100%	0.9333
6JBS_NAG_C_918	91%	71%	0.061	0.948	0.31	0.79	-	-	0	0	100%	0.9333
7YO6_NAG_B_902	84%	57%	0.071	0.932	0.41	1.23	-	1	0	0	100%	0.9333
7EY1_NAG_B_903	80%	28%	0.094	0.966	0.6	2.25	-	5	3	0	87%	0.8667
7EY2_NAG_C_905	74%	47%	0.114	0.945	0.75	1.29	1	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.